153 related articles for article (PubMed ID: 16023352)
1. Lentivirus-mediated expression of glutathione peroxidase: neuroprotection in murine models of Parkinson's disease.
Ridet JL; Bensadoun JC; Déglon N; Aebischer P; Zurn AD
Neurobiol Dis; 2006 Jan; 21(1):29-34. PubMed ID: 16023352
[TBL] [Abstract][Full Text] [Related]
2. Synergy between glutathione peroxidase-1 and astrocytic growth factors suppresses free radical generation and protects dopaminergic neurons against 6-hydroxydopamine.
Gardaneh M; Gholami M; Maghsoudi N
Rejuvenation Res; 2011 Apr; 14(2):195-204. PubMed ID: 21222532
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of glutathione peroxidase-1 expression and activity by glial cell line-derived neurotrophic factor promotes high-level protection of PC12 cells against 6-hydroxydopamine and hydrogen peroxide toxicities.
Gharib E; Gardaneh M; Shojaei S
Rejuvenation Res; 2013 Jun; 16(3):185-99. PubMed ID: 23472740
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of 6-OHDA-induced neurotoxicity in glutathione peroxidase transgenic mice.
Bensadoun JC; Mirochnitchenko O; Inouye M; Aebischer P; Zurn AD
Eur J Neurosci; 1998 Oct; 10(10):3231-6. PubMed ID: 9786216
[TBL] [Abstract][Full Text] [Related]
5. The synergistic effect of beta-boswellic acid and Nurr1 overexpression on dopaminergic programming of antioxidant glutathione peroxidase-1-expressing murine embryonic stem cells.
Abasi M; Massumi M; Riazi G; Amini H
Neuroscience; 2012 Oct; 222():404-16. PubMed ID: 22800564
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress mediated neuronal damage in the corpus striatum of 6-hydroxydopamine lesioned Parkinson's rats: neuroprotection by serotonin, GABA and bone marrow cells supplementation.
Kuruvilla KP; Nandhu MS; Paul J; Paulose CS
J Neurol Sci; 2013 Aug; 331(1-2):31-7. PubMed ID: 23726276
[TBL] [Abstract][Full Text] [Related]
7. Intrastriatal GDNF gene transfer by inducible lentivirus vectors protects dopaminergic neurons in a rat model of parkinsonism.
Chen SS; Yang C; Hao F; Li C; Lu T; Zhao LR; Duan WM
Exp Neurol; 2014 Nov; 261():87-96. PubMed ID: 24997241
[TBL] [Abstract][Full Text] [Related]
8. Surprising behavioral and neurochemical enhancements in mice with combined mutations linked to Parkinson's disease.
Hennis MR; Marvin MA; Taylor CM; Goldberg MS
Neurobiol Dis; 2014 Feb; 62():113-23. PubMed ID: 24075852
[TBL] [Abstract][Full Text] [Related]
9. Preferential resistance of dopaminergic neurons to the toxicity of glutathione depletion is independent of cellular glutathione peroxidase and is mediated by tetrahydrobiopterin.
Nakamura K; Wright DA; Wiatr T; Kowlessur D; Milstien S; Lei XG; Kang UJ
J Neurochem; 2000 Jun; 74(6):2305-14. PubMed ID: 10820190
[TBL] [Abstract][Full Text] [Related]
10. Enhanced efficacy of the CDNF/MANF family by combined intranigral overexpression in the 6-OHDA rat model of Parkinson's disease.
Cordero-Llana Ó; Houghton BC; Rinaldi F; Taylor H; Yáñez-Muñoz RJ; Uney JB; Wong LF; Caldwell MA
Mol Ther; 2015 Feb; 23(2):244-54. PubMed ID: 25369767
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the antiparkinsonism and neuroprotective effects of hydrogen sulfide in acute 6-hydroxydopamine-induced animal model of Parkinson's disease: behavioral, histological and biochemical studies.
Sarukhani M; Haghdoost-Yazdi H; Sarbazi Golezari A; Babayan-Tazehkand A; Dargahi T; Rastgoo N
Neurol Res; 2018 Jul; 40(7):523-531. PubMed ID: 29726751
[TBL] [Abstract][Full Text] [Related]
12. Delayed dominant-negative TNF gene therapy halts progressive loss of nigral dopaminergic neurons in a rat model of Parkinson's disease.
Harms AS; Barnum CJ; Ruhn KA; Varghese S; Treviño I; Blesch A; Tansey MG
Mol Ther; 2011 Jan; 19(1):46-52. PubMed ID: 20959812
[TBL] [Abstract][Full Text] [Related]
13. The Effect of Human Umbilical Cord Mesenchymal Stromal Cells in Protection of Dopaminergic Neurons from Apoptosis by Reducing Oxidative Stress in the Early Stage of a 6-OHDA-Induced Parkinson's Disease Model.
Chi H; Guan Y; Li F; Chen Z
Cell Transplant; 2019 Dec; 28(1_suppl):87S-99S. PubMed ID: 31775521
[TBL] [Abstract][Full Text] [Related]
14. An engineered zinc finger protein activator of the endogenous glial cell line-derived neurotrophic factor gene provides functional neuroprotection in a rat model of Parkinson's disease.
Laganiere J; Kells AP; Lai JT; Guschin D; Paschon DE; Meng X; Fong LK; Yu Q; Rebar EJ; Gregory PD; Bankiewicz KS; Forsayeth J; Zhang HS
J Neurosci; 2010 Dec; 30(49):16469-74. PubMed ID: 21147986
[TBL] [Abstract][Full Text] [Related]
15. Transgenic expression of human glial cell line-derived neurotrophic factor from integration-deficient lentiviral vectors is neuroprotective in a rodent model of Parkinson's disease.
Lu-Nguyen NB; Broadstock M; Schliesser MG; Bartholomae CC; von Kalle C; Schmidt M; Yáñez-Muñoz RJ
Hum Gene Ther; 2014 Jul; 25(7):631-41. PubMed ID: 24635742
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effects of lentivirus-mediated cystathionine-beta-synthase overexpression against 6-OHDA-induced parkinson's disease rats.
Yin WL; Yin WG; Huang BS; Wu LX
Neurosci Lett; 2017 Sep; 657():45-52. PubMed ID: 28764908
[TBL] [Abstract][Full Text] [Related]
17. 3,4-dihydroxybenzalacetone protects against Parkinson's disease-related neurotoxin 6-OHDA through Akt/Nrf2/glutathione pathway.
Gunjima K; Tomiyama R; Takakura K; Yamada T; Hashida K; Nakamura Y; Konishi T; Matsugo S; Hori O
J Cell Biochem; 2014 Jan; 115(1):151-60. PubMed ID: 23959789
[TBL] [Abstract][Full Text] [Related]
18. Functional reinnervation from remaining DA terminals induced by GDNF lentivirus in a rat model of early Parkinson's disease.
Brizard M; Carcenac C; Bemelmans AP; Feuerstein C; Mallet J; Savasta M
Neurobiol Dis; 2006 Jan; 21(1):90-101. PubMed ID: 16084732
[TBL] [Abstract][Full Text] [Related]
19. Autoxidation and neurotoxicity of 6-hydroxydopamine in the presence of some antioxidants: potential implication in relation to the pathogenesis of Parkinson's disease.
Soto-Otero R; Méndez-Alvarez E; Hermida-Ameijeiras A; Muñoz-Patiño AM; Labandeira-Garcia JL
J Neurochem; 2000 Apr; 74(4):1605-12. PubMed ID: 10737618
[TBL] [Abstract][Full Text] [Related]
20. Parkin protects against neurotoxicity in the 6-hydroxydopamine rat model for Parkinson's disease.
Vercammen L; Van der Perren A; Vaudano E; Gijsbers R; Debyser Z; Van den Haute C; Baekelandt V
Mol Ther; 2006 Nov; 14(5):716-23. PubMed ID: 16914382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
